- Home
- TLSA vs BSET Comparison
TLSA vs BSET Comparison
Compare TLSA & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | BSET |
|---|---|---|
| Founded | 2013 | 1902 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.1M | 169.9M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TLSA | BSET |
|---|---|---|
| Price | $1.07 | $19.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 21.4K |
| Earning Date | 05-04-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 5.49% |
| EPS Growth | N/A | ★ 163.06 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $456,855,000.00 |
| Revenue This Year | N/A | $1.72 |
| Revenue Next Year | N/A | $3.78 |
| P/E Ratio | ★ N/A | $51.14 |
| Revenue Growth | N/A | ★ 0.96 |
| 52 Week Low | $0.87 | $13.17 |
| 52 Week High | $2.35 | $22.26 |
Technical Indicators
Market Signals| Indicator | TLSA | BSET |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 45.46 |
| Support Level | $0.90 | $18.78 |
| Resistance Level | $1.17 | $20.81 |
| Average True Range (ATR) | 0.09 | 0.56 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 56.84 | 19.71 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.